Find The Right Clinical Trial For You

Patients and Caregivers

Take control of your medical future and have confidence in your treatment with Third Opinion. Become a member and receive personalized help enrolling in a study near you. Click here to learn more.

Clinical Trial Managers

Reduce trial start up times and patient drop out. Third Opinion members are motivated to join trials and take charge of their health. Our matching software identifies the patients best fitted for your trial. Click here to learn more.

Sponsored Trials

The study aims to test the effectiveness and safety of two different doses of tozorakimab, given via subcutaneous injection, in adults with symptomatic COPD who have experienced at least 2 moderate or 1 severe exacerbation in the previous year and are receiving optimized maintenance inhaled therapy for at least 3 months prior to enrollment.
*Third Opinion AI Generated Synopsis

SAFFRON - Non Small Cell Lung Cancer
The study aims to compare the effectiveness and safety of savolitinib and osimertinib versus platinum-based chemotherapy in patients with non-small cell lung cancer (NSCLC) who have certain genetic mutations and have stopped responding to osimertinib treatment. Specifically, the study will investigate the drug combination's impact on EGFR and MET genes.
*Third Opinion AI Generated Synopsis

Migraine Trial
Vestibular migraine (VM) is a subtype of migraine that causes dizziness as the main symptom affecting 2.7% of the adults in the United States. The researchers have developed a patient-reported outcome tool called VM-PATHI and propose a pilot study to compare the efficacy of Galcanezumab with a placebo arm in reducing dizziness in patients with VM.
*Third Opinion AI Generated Synopsis